iBio Inc. has reported a future insider transaction scheduled for November 21, 2024. The reporting person is Antonio Bernardino Guimaraes Parada, whose relationship to the issuer is not specified in the provided information.The announcement lacks details on the nature, volume, or value of the transaction. It's unclear whether this involves a purchase, sale, or other type of securities transaction. The reporting person's address is listed as c/o iBio, Inc., 11750 Sorrento Valley, Road, Suite 200, San Diego, CA, 92121.Given the limited information available, investors should monitor for further updates or disclosures from iBio Inc. regarding this scheduled transaction. The significance and potential market impact of this event cannot be determined without additional details.

iBio Inc. has reported a future insider transaction scheduled for November 21, 2024. The reporting person is Antonio Bernardino Guimaraes Parada, whose relationship to the issuer is not specified in the provided information.The announcement lacks details on the nature, volume, or value of the transaction. It's unclear whether this involves a purchase, sale, or other type of securities transaction. The reporting person's address is listed as c/o iBio, Inc., 11750 Sorrento Valley, Road, Suite 200, San Diego, CA, 92121.Given the limited information available, investors should monitor for further updates or disclosures from iBio Inc. regarding this scheduled transaction. The significance and potential market impact of this event cannot be determined without additional details.